Questionnaire Survey on the Use of Depot Formulation of Leuprorelin Acetate Injection in Patients with Prostate Cancer (QLIPP)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2018
Price : $35 *
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms QLIPP
- 01 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 08 May 2018 Status changed from not yet recruiting to recruiting.
- 04 Apr 2018 New trial record